首页> 外文期刊>Frontiers in Medicine >Acute Urticaria in Inpatients Undergoing Non-emergent Coronary Angiography With Corticosteroid Prophylaxis: A Retrospective Study
【24h】

Acute Urticaria in Inpatients Undergoing Non-emergent Coronary Angiography With Corticosteroid Prophylaxis: A Retrospective Study

机译:急性荨麻疹在接受非新兴冠状动脉造影的住院患者与皮质类固醇预防:回顾性研究

获取原文
           

摘要

Background and Aims: Acute urticaria (AU) is the most frequently reported immediate hypersensitivity reaction in skin by administration of iodinated contrast media (ICM). We aimed to establish the pattern and identify the risk factors of AU among inpatients undergoing non-emergent coronary angiography (CAG) with prophylactic corticosteroids in China. Methods: Medical records of 19,326 adult inpatients undergoing non-emergent CAG with prophylactic methylprednisolone in 2013–2019 were retrospectively investigated. AU was identified within 1 h post-ICM administration, and diffuse involvement was defined when wheals occur in two or more body parts, including the back, abdomen, chest, and extremities. Age- and sex-matched inpatients (1:4) without AU were randomly selected for assessment of risk factors. Results: Approximately 0.8% of CAG inpatients had AU, including 101 diffuse and 64 limited form. The diffuse AU was more common in settings of non-diagnostic CAG, iohexol used, average ICM injection≥3 ml/min, recurrent CAG, and past history of immediate hypersensitivity to ICM. Inpatients with preexisting allergies, decreased evaluated glomerular filtration rate, and increased high sensitivity C reactive protein or neutrophil-to-lymphocyte ratio prior to CAG had a higher probability of AU (odds ratio 1, P 0.05 for all variables). All AU inpatients complained of pruritus, and mild itching predominated. AU dissipated in several days under treatment of ebastine or levocetirizine 10 mg/daily, but ebastine showed superiority. Conclusions: ICM-induced AU is not uncommon in non-emergent CAG inpatients with prophylactic methylprednisolone. Preexisting allergies, renal dysfunction, and mild inflammation are high-risk factors, and antihistamine monotherapy is a favorable candidate for ICM-related AU.
机译:背景和目的:急性荨麻疹(AU)是通过施用碘化造影剂(ICM)的皮肤上最常报告的即时过敏反应。我们的目标是建立模式,并确定在中国预防性皮质类固醇中经历非新兴冠状动脉造影(CAG)的住院患者中AU的危险因素。方法:回顾性研究了2013 - 2019年在预防性甲基丙酮中接受非紧急CAG的19,326名住院患者的病程。在ICM后1小时内鉴定出AU,并且当发生两种或更多个身体部位时,包括背部,腹部,胸部和四肢的散发,定义了漫反射参与。无菌的年龄和性匹配的住院病人(1:4)被随机选择评估风险因素。结果:约0.8%的CAG住院患者具有AU,包括101个漫射和64个有限形式。在非诊断CAG的环境中,弥漫性Au更常见,使用的碘注射率,平均ICM注射≥3ml/ min,复发性CAg以及对ICM的立即超敏反期的历史。在CAG之前,具有预先存在的过敏,降低评估的肾小球过滤速率,以及增加的高灵敏度C反应蛋白或中性粒细胞对淋巴细胞比率的高敏感性C的损失,具有较高的Au(ODS比率和GT; 0.05对于所有变量,P <0.05)。所有au住院患者抱怨瘙痒,并温和瘙痒占主导地位。 Au在治疗eBastine或左甲齐齐嗪10毫克/每日治疗的几天内消散,但是Ebastine显示出优越性。结论:ICM诱导的Au在具有预防甲基己酮醇的非新芽CAG住院患者中并不少见。预先存在的过敏,肾功能不全和轻度炎症是高危因素,抗组胺药单疗法是ICM相关AU的有利候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号